Zika Virus- Emergence, Evolution, Pathology, Diagnosis, and Control: Current Global Scenario and Future Perspectives- A Comprehensive Review by Singh, Raj K. et al.
Old Dominion University
ODU Digital Commons
Bioelectrics Publications Frank Reidy Research Center for Bioelectrics
2016
Zika Virus- Emergence, Evolution, Pathology,
Diagnosis, and Control: Current Global Scenario






See next page for additional authors
Follow this and additional works at: https://digitalcommons.odu.edu/bioelectrics_pubs
Part of the Public Health Commons, Veterinary Medicine Commons, and the Viruses Commons
This Article is brought to you for free and open access by the Frank Reidy Research Center for Bioelectrics at ODU Digital Commons. It has been
accepted for inclusion in Bioelectrics Publications by an authorized administrator of ODU Digital Commons. For more information, please contact
digitalcommons@odu.edu.
Repository Citation
Singh, Raj K.; Dhama, Kuldeep; Malik, Yashpal S.; Ramakrishnan, Muthannan A.; Karthik, Kumaragurubaran; and Joshi, Sunil K.,
"Zika Virus- Emergence, Evolution, Pathology, Diagnosis, and Control: Current Global Scenario and Future Perspectives- A
Comprehensive Review" (2016). Bioelectrics Publications. 168.
https://digitalcommons.odu.edu/bioelectrics_pubs/168
Original Publication Citation
Singh, R. K., Dhama, K., Malik, Y. S., Ramakrishnan, M. A., Karthik, K., Tiwari, R., . . . Joshi, S. K. (2016). Zika virus - emergence,
evolution, pathology, diagnosis, and control: current global scenario and future perspectives - a comprehensive review. Veterinary
Quarterly, 36(3), 150-175. doi:10.1080/01652176.2016.1188333
Authors
Raj K. Singh, Kuldeep Dhama, Yashpal S. Malik, Muthannan A. Ramakrishnan, Kumaragurubaran Karthik,
and Sunil K. Joshi
This article is available at ODU Digital Commons: https://digitalcommons.odu.edu/bioelectrics_pubs/168
REVIEW ARTICLE
Zika virus  emergence, evolution, pathology, diagnosis, and control: current
global scenario and future perspectives  a comprehensive review
Raj Kumar Singha, Kuldeep Dhama b, Yashpal Singh Malik c, Muthannan Andavar Ramakrishnand,
Kumaragurubaran Karthik e, Ruchi Tiwarif, Sharad Saurabhc, Swati Sachang and Sunil Kumar Joshih
aICAR-Indian Veterinary Research Institute, Bareilly, India; bDivision of Pathology, ICAR-Indian Veterinary Research Institute, Bareilly, India;
cDivision of Biological Standardization, ICAR-Indian Veterinary Research Institute, Bareilly, India; dDivision of Virology, ICAR-Indian
Veterinary Research Institute, Mukteswar Campus, Uttarakhand, India; eDivision of Bacteriology and Mycology, ICAR-Indian Veterinary
Research Institute, Bareilly, India; fDepartment of Veterinary Microbiology and Immunology, College of Veterinary Sciences, Deen Dayal
Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan, Mathura, India; gImmunology Section, ICAR-Indian
Veterinary Research Institute, Bareilly, India; hCellular Immunology Lab, Frank Reidy Research Center for Bioelectrics, School of Medical
Diagnostics & Translational Sciences, Old Dominion University, Norfolk, VA, USA
ARTICLE HISTORY
Received 4 March 2016
Accepted 7 May 2016
ABSTRACT
This review converses the Zika virus which has attained global concern due to its rapid
pandemic potential and impact on humans. Though Zika virus was first isolated in 1947, till the
recent large-scale outbreak which occurred in Micronesia, in 2007, the virus was placed into the
innocuous pathogen category. The World Health Organization on 1 February 2016 declared it
as a ‘Public Health Emergency of International Concern.’ Of the note, American as well as Pacific
Island strains/isolates is relatively closer to Asian lineage strains. The African and American
strains share more than 87.5% and 95% homologies with Asian strains/isolates, respectively.
Asian strains form independent clusters, except those isolated from China, suggesting relatively
more diversity than African strains. Prevention and control are mainly aimed at the vector
population (mosquitoes) with Aedes aegypti being the main species. Surveys in Africa and Asia
indicated seropositivity in various animal species. However, so far its natural reservoir is
unknown. There is an urgent need to understand why Zika virus has shifted from being a virus
that caused mild illness to unforeseen birth defects as well as autoimmune-neurological
problems. Unfortunately, an effective vaccine is not available yet. Availability of cryo-electron
microscopy based on 3.8 A

resolution revealing mature Zika virus structure and the probable
virus attachment site to host cell would provide critical insights into the development of
antiviral treatments and vaccines.
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1. Introduction
The geographic modulations, in terms of population
and climate dynamics, have become a potential threat
to the global community health in past, in particular
due to uprising infection rates of mosquito-borne dis-
eases such as Malaria, Chikungunya, Dengue, West
Nile, and Zika (Chen & Wilson 2010; Dhiman et al. 2010;
Dhama, Tiwari, et al. 2013; Lee et al. 2013; Hubalek
et al. 2014; Carneiro & Travassos 2016; Fauci &
Morens 2016). The animal and vector-borne (primarily
ticks and mosquitoes) viral diseases are of major con-
cern due to their easy and accelerated migration across
the continents (Hubalek et al. 2014). In the past
60 years, several deadly disease outbreaks in man
resulted from the emergence of viruses of animal ori-
gin such as Henipaviruses (Hendra, Nipah, and Cedar
virus) in Australia (Ong & Wong 2015), Hantavirus in
the United States of America (Knust & Rollin 2013),
Ebola virus in Africa (Martınez et al. 2015; Nunes-Alves
2016), several influenza subtypes (bird flu, swine flu,
etc.) (Kapoor and Dhama 2014), severe acute respira-
tory syndrome (SARS) and the Middle East respiratory
syndrome (MERS). Recently, it was Ebola that threat-
ened the whole world by its outrageous nature
(Dhama, Malik, et al. 2015; Martınez et al. 2015; Nunes-
Alves 2016) and now it is time for Zika virus which has
already set the floor on fire due to its rapid and wider
spread (Fauci & Morens 2016). The Zika outbreaks are
more challenging, as they are unpredictable and rap-
idly spreading among the affected people (Hayes
2009; Gautret & Simon 2016; Grard et al. 2014; Gatherer
& Kohl 2016; Gulland 2016a). Moreover, least is known
about disease ecology and further lack of effective pre-
vention and treatment options worsen the situation
(Elachola et al. 2016; Petersen, Wilson, et al. 2016). Zika
virus raised concern in the recent past because of its
worldwide spread whereas earlier it was found limited
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only to two of its dwelling continents, Africa and Asia
(Heang et al. 2012; Brown 2015; Lucey & Gostin 2016;
WHO 2016).
The viruses of the Flaviviridae family found in arthro-
pods (primarily in ticks and mosquitoes) can occasion-
ally infect humans (Chastel 2012; Choumet & Despres
2015). Members of this family belong to a single genus,
Flavivirus, associated with considerable morbidity and
mortality throughout the world. Some of the tick-
transmitted viruses are responsible for encephalitis and
hemorrhagic diseases viz. tick-borne encephalitis (TBE),
Kyasanur Forest Disease (KFD), Alkhurma Disease, and
Omsk Hemorrhagic Fever (OHF). Several other flavivi-
ruses such as Japanese encephalitis, Yellow Fever, West
Nile, Dengue, Chikungunya, and Zika virus are being
transmitted by the mosquitoes (Daep et al. 2014;
Hubalek et al. 2014; Medlock & Leach 2015; Parham
et al. 2015). North America has been victimized by the
emergence of several arthropod-borne diseases, includ-
ing Jamestown Canyon, Powassan, Chikungunya, and
Zika diseases recently (Pastula et al. 2016). Due to recent
outbreaks, Zika virus (Fauci & Morens 2016) is being
considered as an emerging infectious disease with the
potential to spread to new areas where the Aedes mos-
quito vector is present (Hayes 2009; Chen & Wilson
2010; Cao-Lormeau et al. 2014; Carneiro & Travassos
2016; CDC 2016; Hennessey et al. 2016) and reports also
document the involvement of other vectors like Culex
spp. (Marcondes et al. 2016).
Zika virus possesses an un-segmented, single-
stranded, positive-sense RNA genome of approxi-
mately 11 kb and its single open reading frame (ORF)
(10272 bp) encodes a polyprotein which includes three
structural proteins viz., capsid, pre-membrane, and
envelope and seven non-structural (NS) proteins (NS1,
NS2a, NS2b, NS3, NS4a, NS4b, and NS5). Hitherto stud-
ies elucidate phylogenetic relationship among Zika
virus strains targeting selected genes (e.g. envelope,
NS3, NS5, etc.) from a few strains/isolates. Still, we are
falling short of a broad spectrum picture about Zika
virus evolution.
The first Zika virus isolation was done in 1947 (Dick
et al. 1952). Since the Zika disease outbreak in Brazil
during early 2015 (Zanluca et al. 2015; WHO 2016;
Rodriguez-Morales 2015; Nereida 2015), the disease is
spreading rapidly across South and Central America,
and Mexico (Summers et al. 2015). After Brazil, Colom-
bia is the most-affected country, with well over 25,000
suspected human cases reported and 1331 Zika virus
cases confirmed in man since October 2015 (Petersen,
Wilson, et al. 2016; Roa 2016). These outbreaks are
more challenging as they are unpredictable and rapidly
emerging/spreading among the people affected. Con-
sidering the above situation, the WHO on 1 February
2016, declared it as a ‘Public Health Emergency of
International Concern’ (WHO 2016; Gulland 2016b;
Higgs 2016).
As of 30th March 2016, locally transmitted (autoch-
thonous) cases of Zika virus infection have been
reported from 61 countries or territories worldwide
(Zanluca et al. 2015; Calvet, Filippis, et al. 2016). In liter-
ature, Zika disease is described as a mild, self-limiting
febrile illness lasting four to nine days without severe
complications, no fatalities, and a low hospitalization
rate (CDC 2016). There is a link between Zika virus
spread and an increase in cases of fetal abnormalities
like microcephaly, hydranencephaly, ventriculomegaly,
cerebral calcifications, abnormally formed or absence
of brain structures, cataracts of both eyes, calcifications
of eye, and hydrops fetalis during pregnancy and yet
an unproven association with GuillainBarre syndrome
(GBS) in adult people (Oehler et al. 2014; de Paula Frei-
tas et al. 2016; Karwowski et al. 2016). Since October
2015, more than 4000 babies in Brazil had been born
with abnormally small heads and brains  a rare condi-
tion known as microcephaly (Martines et al. 2016;
Schuler-Faccini et al. 2016; Mlakar et al. 2016; Rodri-
guez-Morales 2016; Heymann et al. 2016). The Zika
virus transmission occurs through the Aedes mosquito,
perinatal transmission (Besnard et al. 2014), sexual
intercourse, and blood transfusion (Musso, Nhan, et al.
2014; Franchini & Velati 2015). From infected pregnant
mothers, the Zika virus can be transmitted via transpla-
cental route and as a consequence might affect the
developing brain of the fetus (Roa 2016; Rodriguez-
Morales 2016; Torjesen 2016). The methods available
for diagnosis of Zika virus include real-time (RT) poly-
merase chain reaction (PCR) (Faye et al. 2008; Gourinat
et al. 2015) and IgM-based ELISAs, with the latter one
suffering from limitation of cross-reaction of antibodies
with other Flaviviruses (Buathong et al. 2015). Currently,
there is no effective treatment for this disease. Though
vaccination seems to be a promising option for con-
trolling the disease, no effective vaccine against Zika
disease is available yet (Dyer 2016a). Prevention and
control are the only available weapon in the arsenal to
keep this disease under check. Several approaches for
controlling mosquito population like mechanical con-
trol, use of chemicals, and genetic control methods are
available (Araujo et al. 2015). The WHO has issued an
alert to the public regarding Zika disease on 1 February
2016 (Citrome 2016). The guidelines issued recently
need to be followed to prevent further spread of dis-
ease. Strict biosecurity measures need to be adopted
worldwide in order to prevent further spread of the
disease to different parts of the world.
2. Etiology
The family Flaviviridae comprises of four genera viz., 1.
Flavivirus (53 Species), Hepacivirus (one Species),
Pegivirus (two Species), and Pestivirus (four Species)
(http://www.ictvonline.org/virusTaxonomy.asp). Based
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on virus transmission, the genus Flavivirus is further
divided into three major groups viz., (1) tick-borne
viruses (mammalian tick-borne virus group, seabird
tick-borne virus group), (2) mosquito-borne viruses
(Aroa virus group, Dengue virus group, Japanese
encephalitis virus group, Kokobera virus group, Ntaya
virus group, Spondweni virus group, and Yellow Fever
virus group), and (3) viruses with no known arthropod
vector (Entebbe bat virus group, Modoc virus group,
and Rio Bravo virus group). The Zika virus belongs to
the genus Flavivirus and is a representative of the
Spondweni virus group of mosquito-borne virus group.
The viruses in the genus flavivirus possess a single-
stranded, positive-sense RNA genome of approxi-
mately 11 kbp with a 50-type I cap structure that is
methylated at the guanine N-7 and the ribose 20-OH
positions of the first transcribed nucleotide adenine
(m7GpppAm) (Ray et al. 2006). The RNA cap structure
is crucial for RNA stability and translation (Picard-Jean
et al. 2013). The particle size of Zika virus (strain 766)
was estimated to be between 30 and 45 nm (Dick
1952). The earlier reports speculated that phylogeneti-
cally Zika virus relates more closely to Spondweni virus;
the two viruses are the only members of their clade
within the mosquito-borne cluster of flaviviruses (Kuno
et al. 1998; Cook & Holmes 2006; Lanciotti et al. 2008;
Hayes 2009).
Recently, the Zika virus structure was decipehreed
using cryo-electron microscopy with 3.8 A

resolution.
Higher similarity exists with other Flavivirus members
excepting for nearly 10 amino acids which enfold the
Asn154 glycosylation site and constitutes the icosahe-
dral shell. Furthermore, the probable virus attachment
site to the host cell was predicted, where any change
can alter further virus transmission and disease pro-
gression. This provides critical insights into the devel-
opment of antiviral treatments and vaccines in days to
come (Sirohi et al. 2016).
3. Zika virus genomic configuration
As on 31st March 2016, 59 complete coding sequences
and/or genome information is available on Zika virus
in the public database, representing human (n D 39),
monkey (n D 7), and Aedes mosquito (n D 13) isolates
(Table 1). In 2007, for the first time, two full-length
sequences of Zika virus strain ‘MR 766’ from monkey
(NC_012532 and AY632535) were deposited to the
database by Kuno and Chang from the National Center
for Zoonotic, Vector-Borne, and Enteric Diseases, USA.
The former sequence is being considered as the refer-
ence sequence. With the advancement in next genera-
tion sequencing platforms, the database was
continuously enriched with the addition of new
strains/isolates, with the highest number of submission
of Zika viral sequences (n D 44) in the year 2016 itself.
As per the genomic information available, the ORF
within the Zika virus genome ranges between 10,254
and 10,272 nucleotides, encoding a polyprotein of
3417 (e.g. isolates ARB15076 from mosquito and MR
766 from monkey) to 3423 amino acid residues as
depicted in Table 1. The insertion of few amino acids is
seen at position 441–442 in the genomic region end-
coding E protein. This observation needs further analy-
sis regarding their role in hostpathogen interaction
or other functions. Of the note, all human Zika virus
strains/isolates possess a polyprotein of 3423 amino
acids, whereas, Zika virus with smaller polyprotein
could only be isolated from mosquitos and monkey
(Table 1). Deletion of certain amino acids in polyprotein
may be attributed to the passage history of a particular
strain; however, it needs strong experimental support
(Haddow et al. 2012). The un-translated regions (UTRs)
in Flaviviruses contain conserved sequences (desig-
nated as CS1, CS2, and CS3) that are believed to play
important roles in genome stabilization and genomic
cycle such as recognition by cellular or viral factors,
translation, RNA packaging, replication, etc. (Linden-
bach & Rice 2003; Kuno & Chang 2007). It is noteworthy
that variation in CS1 and CS3 is also reported in Zika
virus strain MR 766 (Kuno & Chang 2007). Likewise,
polymorphism (additions as well as deletions) in length
of Zika viral polyproteins is also reported in a few
strain/isolates (Haddow et al. 2012; Berthet et al. 2014).
It would be of interest to know what causes the poly-
morphism in length of Zika viral polyproteins and to
explore if this phenomenon has any influence/role on
viral replication and pathogenicity. The polyprotein is
co- and post-translationally cleaved by host and viral
proteases to generate three structural proteins,
designated the capsid (C), membrane precursor/mem-
brane (prM/M) and envelope (E) proteins, and seven
NS proteins in the gene order: 5'CprM(M)
ENS1NS2ANS2BNS3NS4A2KNS4BNS5-3'
(Rice et al. 1985; Blitvich & Firth 2015; Baronti et al.
2014). These three structural proteins (C, prM, and E)
form capsids and seven NS proteins are involved in the
assembly and viral replication. The Zika virus envelope
plays a role in various aspects of the life cycle including
binding and membrane fusion (Lindenbach & Rice
2003). The protein C (core protein; 11 kDa) is important
for the formation of the nucleocapsid; protein E
(50 kDa  the largest structural protein) is an envelope
glycoprotein functioning as a fusion protein and it is
the primary target for neutralizing antibodies. The pro-
tein M (8 kDa) is translated as precursor protein viz;
‘prM’ (26 kDa), which is cleaved by a cellular enzyme
(furin) into mature protein M  and a ‘pr’ segment at
the time of virion release from the cell. The prM com-
plex protects protein E from degradation during virion
assembly. The ‘pr’ and the M proteins can provide host
protection from infection. The seven NS proteins play a
vital role in replication of the flaviviruses and invoking
cell-mediated immune response (Ryan et al. 1998;
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Zhang et al. 2003; Bollati et al. 2010; Shiryaev &
Strongin 2010; Smit et al. 2011; Blitvich & Firth 2015).
The structure of Zika virus and its genome is depicted
in Figure 1. The NS5, being the largest, serves as a
multi-tasking protein, as its C-terminus performs RNA-
dependent RNA polymerase (RdRP) activity while the
N-terminus possesses methyltransferase activity and is
involved in RNA capping (Lindenbach & Rice 2003).
Zika virus genome encodes for only 10 proteins.
Hence, it may be assumed that one or more proteins
Table 1. Details of Zika virus strains/isolates (full length or near to full length sequences) available in the database.
S. No. Host Strain/isolate Country Year# Accession No. CDS (nucleotide) Polyprotein (amino acid)
Mosquito
1 A. aegypti P6-740 Malaysia 1966 HQ234499 10,269 3423
2 A. africanus ArB1362 CAR 1968 KF383115 10,272 3423
3 A. luteocephalus ArD7117 Senegal 1968 KF383116 10,272 3423
4 A. africanus Isolate ARB13565 CAR 1976 KF268948 10,269 3422
5 A. africanus Isolate ArD_41519 Senegal 1984 HQ234501 10,269 3423
6 A. taylori 41662-DAK-tc Senegal 1984 KU955592 10,272 3423
7 A. africanus 41525-DAK-tc Senegal 1984 KU955591 10,272 3423
8 A. taylori 41671-DAK-tc Senegal 1984 KU955595 10,272 3423
9 A. luteocephalus ArD128000 Senegal 1997 KF383117 10,272 3423
10 A. dalzieli ArD157995 Senegal 2001 KF383118 10,272 3423
11 A. dalzieli ArD158084 Senegal 2001 KF383119 10,272 3423
12 A. opok Isolate ARB15076 CAR 2013 KF268949 10,254 3417
13 A. africanus Isolate ARB7701 CAR 2014 KF268950 10,269 3422
Human
1 H. sapiens IbH_30656 Nigeria 1968 HQ234500 10,251 3417
2 H. sapiens EC Yap Micronesia 2007 EU545988 10,272 3423
3 H. sapiens Isolate FSS13025 Cambodia 2010 JN860885 10,269 3423
4 H. sapiens FSS13025-tc Cambodia 2010 KU955593 10,272 3423
5 H. sapiens Isolate CPC-0740 Philippines 2012 KU681082 10,269 3423
6 H. sapiens H/PF/2013 French Polynesia 2013 KJ776791 10,272 3423
7 H. sapiens Haiti/1225/2014

Haiti 2014 KU509998 10,272 3423
8 H. sapiens Isolate SV0127/14 Thailand 2014 KU681081 10,269 3423
9 H. sapiens ZikaSPH2015

Brazil 2015 KU321639 10,272 3423
10 H. sapiens PRVABC59

Puerto Rico 2015 KU501215 10,272 3423
11 H. sapiens Isolate Z1106033 Suriname 2015 KU312312 10,272 3423
12 H. sapiens BeH818995 Brazil 2015 KU365777 10,272 3423
13 H. sapiens BeH819015 Brazil 2015 KU365778 10,272 3423
14 H. sapiens BeH819966{ Brazil 2015 KU365779 10,272 3423
15 H. sapiens BeH815744 Brazil 2015 KU365780 10,272 3423
16 H. sapiens 8375 Guatemala 2015 KU501217 10,272 3423
17 H. sapiens MRS_OPY_Martinique_
PaRi_2015
Martinique 2015 KU647676 10,272 3423
18 H. sapiens Natal RGN Brazil 2015 KU527068 10,272 3423
19 H. sapiens ZKV2015 Brazil 2015 KU497555 10,272 3423
20 H. sapiens SSABR1 Brazil 2015 KU707826 10,272 3423
21 H. sapiens FLR Colombia 2015 KU820897 10,272 3423
22 H. sapiens BeH828305 Brazil 2015 KU729218 10,272 3423
23 H. sapiens BeH823339 Brazil 2015 KU729217 10,272 3423
24 H. sapiens 103344 Guatemala 2016 KU501216 10,272 3423
25 H. sapiens ZJ03 China 2016 KU820899 10,272 3423
26 H. sapiens VE_Ganxian China 2016 KU744693 10,272 3423
27 H. sapiens Dominican Republic/2016/PD1 Italy 2016 KU853012 10,272 3423
28 H. sapiens Dominican Republic/2016/PD2 Italy 2016 KU853013 10,272 3423
39 H. sapiens MEX/InDRE/Lm/2016 Mexico 2016 KU922923 10,272 3423
30 H. sapiens MEX/InDRE/Sm/2016 Mexico 2016 KU922960 10,272 3423
31 H. sapiens Rio-U1 Brazil 2016 KU926309 10,272 3423
32 H. sapiens Rio-S1 Brazil 2016 KU926310 10,272 3423
33 H. sapiens FB-GWUH-2016 USA 2016 KU870645 10,272 3423
34 H. sapiens Z16006 China 2016 KU955589 10,272 3423
35 H. sapiens Z16019 China 2016 KU955590 10,272 3423
36 H. sapiens GDZ16001 China 2016 KU761564 10,272 3423
37 H. sapiens GD01{ China 2016 KU740184 10,272 3423
38 H. sapiens GZ01 China 2016 KU820898 10,272 3423
39 H. sapiens SZ01 China 2016 KU866423 10,272 3423
Monkey
1 M. mulatta MR 766 Uganda 1947 HQ234498 10,269 3423
2 M. mulatta MR-766-tc Uganda 1947 KU955594 10,260 3419
3 M. mulatta MR 766-tc Uganda 1947 KU720415 10,272 3423
4 M. mulatta MR 766 Uganda 2006 DQ859059 10,254 3417
5 M. mulatta MR 766
{ Uganda 2010 AY632535 10,260 3419
6 M. mulatta MR766-NIID

Uganda 2014 LC002520 10,272 3423
7 M. mulatta MR 766
x Uganda 2016 NC_012532 10,260 3419




{Putative ancestral sequences (please refer Figure 3). CAR; Central African Republic, tc; Cell cultured strains/isolates.
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may possess post-translational modifications (PTM) to
exert different functions. PTM is a crucial phenomenon
that leads to altered protein function in various sub-
cellular locations. It becomes further important when
genome size is less and only a few proteins are trans-
lated as in the case of viruses. A number of putative N
and O-linked glycosylation sites have been predicted
in a few proteins viz., membrane, envelope, and NS1 of
several Zika virus strains (Kuno & Chang 2007; Lanciotti
et al. 2008; Haddow et al. 2012; Faye et al. 2014).
N-linked glycosylation is known to be important in
infectivity and assembly of flaviviruses (Mondotte et al.
2007; Lee et al. 2010). The glycosylation sites in Zika
virus genome exhibit polymorphism and may have
adaptive values during evolution. It is imperative to
remark here that loss of glycosylation sites occurs in
Zika viruses (Haddow et al. 2012; Hanna et al. 2005; Lee
et al. 2010). Recently, the correlation between glycosyl-
ation sites polymorphism and the vector was sug-
gested to cause the evolution of Zika viruses (Faye
et al. 2014). Though the absence of glycosylation may
be important for the sylvatic cycle of the virus (Mon-
dotte et al. 2007), the functional importance of glyco-
sylation is still a matter of research.
Moreover, we predicted putative phosphorylation
sites in the polyprotein from different Zika virus strains
isolated from human (Haiti/1225/2014, n D 156, and
ZikaSPH2015, n D 155), monkey (MR 766, n D 148),
and mosquito (ARB7701, n D 146) following the
method described earlier (Chattopadhyay et al. 2010).
Likewise, sites for potential SUMOylation could also be
predicted with a high threshold in human (Haiti/1225/
2014, n D 4, and ZikaSPH2015, n D 4), monkey (MR
766, n D 6), and mosquito (ARB7701, n D 5) Zika virus
polyproteins. Till date, only glycosylation sites are
reprted in Zika viral proteins, whereas predictions
emerged out of the analysis we conducted suggest the
presence of other PTM modifications also. Biological
functions such as the proteinprotein interaction of
proteins are known to be influenced by phosphoryla-
tion, whereas SUMOylation provides functional flexibil-
ity to proteins and is involved in different biological
phenomena such as protein localization and functions.
Hence, future Zika virus research strategies should also
include exploration of PTM in polyproteins and their
biological significance.
4. Zika virus evolution
To study the Zika virus evolution, complete genome
sequences encoding polyprotein were retrieved from
NCBI database (n D 59) and subjected to the phyloge-
netic analysis with the help of MEGA (Molecular Evolu-
tionary Genetic Analysis version 6.05) tool (Tamura
et al. 2013). Nucleotide sequences were aligned using
the default pairwise and multiple alignment parame-
ters of ClustalW in MEGA and applied for selection of
the best substitution model for further analysis using
FindModel tool (http://www.hiv.lanl.gov/content/
sequence/findmodel/findmodel.html). Gaps were
Figure 1. Structure of Zika virus and its genome. Zika possess ssCve sense RNA which has seven non-structural genes and three
structural genes (C, M, E). M exists as prM (immature form) which gets cleaved to pr and M with the aid of furin enzyme.
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positioned to minimize nucleotide mismatches and
treated as missing data in all analyses. The Maximum
likelihood statistical method was applied to construct a
phylogenetic tree with the GTR C G C I model. The
robustness of tree was tested using the bootstrap
method based on 1000 replicates. Branch correspond-
ing to partitions reproduced in <50% bootstrap repli-
cates was collapsed. The genealogy of Zika virus was
studied to identify the ancestral sequence(s) among
the existing viral populations by TCS network (Clement
et al. 2000) implemented in PopART i.e. Population
Analysis with Reticulate Trees software version 1.7
(http://popart.otago.ac.nz).
Hitherto studies report evolutionary analysis of pan-
demic Zika virus with elucidation of genetic relation-
ship among different Zika virus strains/isolates
(Lanciotti et al. 2008; Haddow et al. 2012; Faye et al.
2014; Berthet et al. 2014; Grard et al. 2014; Buathong
et al. 2015; Gatherer & Kohl 2016) based either on a
few genes e.g. envelope, NS3, NS5, etc. (Lanciotti et al.
2008; Faye et al. 2014; Grard et al. 2014) or some
strains/isolates (Haddow et al. 2012; Gatherer & Kohl
2016; Buathong et al. 2015). Use of envelope and other
non-structural genes (NS5) for phylogenetic analysis in
most of the studies could be attributed to the presence
of high phylogenetic signal contents in these genes
(Faye et al. 2014). Broadly, these studies have outlined
that all Zika virus strains/isolates cluster into two major
clades, one representing the African and the other the
Asian lineage. The African lineage is further grouped
into two sub-clades, the MR766 prototype clade from
East Africa (Ugandan cluster) and another from West
Africa (Nigerian cluster) (Haddow et al. 2012; Faye et al.
2014; Berthet et al. 2014; Grard et al. 2014; Gatherer &
Kohl 2016; Buathong et al. 2015). The African and
American strains share more than 87.5% and 95%
homologies with Asian strains/isolates, respectively
(data not shown). The phylogenetic analysis carried
out herein, targeting ORF of polyprotein gene, was in
agreement with previous observations based on
selected genes. Moreover, it also supported the notion
that American as well as Pacific Island strains/isolates
are relatively closer to those from Asian lineage
(Zanluca et al. 2015; Buathong et al. 2015; Alera et al.
2015; Enfissi et al. 2016). The African strains clustered
together forming three sub-clades representing strains
from West Africa, Central African Republic (CAR), and
East Africa, respectively (Figure 2). This observation
was also evident in TCS network analysis, where Asian
and African lineages also exhibit clear distance
(Figure 3). There were few variations observed in Asian
and American lineage, as strains/isolates from Ameri-
cas and Carrebian Islands exhibited diversity and
formed four different clusters (Figure 2). Asian strains
formed independent clusters, except those isolated
from China, suggesting relatively more diversity than
African Zika viral strains. Between the two Zika viral
lineages, the Asian lineage is thought to have evolved
with higher epidemic potential (Kelser 2016) in line
with with the diversity seen in Asian lineage strains.
Furthermore, strains from Pacific Islands (two represen-
tations in our study) clustered distinctly in the phylo-
gram. The strain that caused the outbreak in
Micronasia (2007) clustered with those from Phillipines
and Malaysia, while that from French Polynesia formed
an independent cluster. It was concomitant with previ-
ous phylogenetic observations (Enfissi et al. 2016). Of
the note, two isolates from Italy (Accession no.
KU853012-13) were found to have closer similarity
with Brazilian isolates. Further examination revealed
that these two actually belong to Dominican Republic
and were carried to Italy with a traveler (Barzon et al.
2016). Strains from Senegal in African lineage were
present in two sub-clades from West and East Africa as
observed earlier (Faye et al. 2014) which hypothesize
the presence of more than one distinct lineage in Sen-
egal (Faye et al. 2014). Likewise, strains from China as
well as Brazil were also part of different sub-clades,
suggesting circulation of more than one type of Zika
viral population in those regions (Figure 2). Especially
Brazilian isolates exhibit highest diversity among them
when compared to strains/isolates from any other
country. This diverse Zika viral population may pose
serious challenge to Zika viral vaccination research in
the continent. Phylogenetic studies by other research-
ers on Zika virus also emphasized that it emerged in
Uganda (most probably the strain ‘MR 766’ accession
no. AY632535, as evidenced in our analysis also;
Figure 3). This emergence is followed by movement of
the virus towards East African countries such as Sene-
gal, Nigeria, and CAR. The Asian lineage also emerged
from African strain (from Uganda), moved towards
Pacific Islands causing epidemic in Micronesia (Faye
et al. 2014; Gatherer & Kohl 2016; Buathong et al. 2015;
Alera et al. 2015) and eventually reached the Americas
(Gatherer & Kohl 2016; Zanluca et al. 2015). Addition-
ally, TCS network suggested two more putative ances-
tral sequences of human origin circulating in China
(GD01; KU740184) and Brazil (BeH819966; KU365779).
Our observation advocates the school of thought that
the Zika virus was widely distributed throughout the
distinctly situated continents such as Africa, Asia, and
America since long (Faye et al. 2014). Therefore, time
and place of isolation might not be linked to their
spread.
Recently, recombination events  although a rare
phenomenon in Flaviviruses (Loriere and Holmes 2011)
 are also found with significant statistical support in
different Zika viral strains (Faye et al. 2014). The study
advocated that recombinations are also being experi-
enced by Zika viruses in the field. However, the occur-
rence of this phenomenon in Zika viruses should be
addressed with additional strain/isolates available in
the database and eventually must be evaluated for
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their impact on pathogen distribution, epidemiologi-
cal, and zoonotic potential. Additionally, the study also
identified that a few Zika viral genes e.g. envelope and
NS5 are under strong negative selection pressure.
Infection and transmission mode of RNA viruses such
as Zika viruse permit the negatively selected sites and
synonymous substitutions (Hanada et al. 2004). Hence,
episodes of negative selections together with no sign
of positive selection are indicative of eradication of
unwanted polymorphism in genes with functional
Figure 2. Phylogenetic analysis of genes encoding polyprotein in Zika virus. Maximum likelihood tree was generated from nucleo-
tide sequences of 59 Zika virus strains (complete open reading frame) retrieved from GenBank utilizing the GTR C G C I model.
The tree was rooted with Spondweni virus reference sequence (GenBank accession number NC_029055). Numbers at the nodes
represent percentage bootstrap support values based on 1000 replicates. Strains/isolates are represented according to their name,
accession number, country of origin, and year of collection/isolation/submission. Strains from Americas (1a1c) together with those
from Asian and Oceania constituted the Asian-American lineage and grouped into 1a, 1b, 1c, and 1d. The African strains/isolates
clustered to form the African lineage and grouped into east (2a), central (2b) and west (2c) African sub-clades.
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significance. One can assume that deletions that remove
glycosylation sites in the envelope gene which, in turn,
increase the infectivity of Zika virus and the outbreak of
Zika virus is due to negative selection. However, all these
speculations need experimental validation. One specula-
tion is that Zika virus undergoes recombination and due
to loss of its N154 glycosylation site in the envelope
protein got adapted to Aedes dalzieli, a mosquito vector
in Africa (Faye et al. 2014).
5. Epidemiology, transmission, and spread
In recent times, a lesser known mosquito-borne virus,
Zika virus, is emerging as a serious public health
Figure 3. The genealogy of Zika viral strains/isolates. The TCS network showing 59 haplotypes connected parsimoniously. Individual
discs indicate haplotypes with the size of the disc proportional to the number of accessions in the haplotype. Strains viz; ‘MR 766’
from monkey (AY632535), BeH819966 (KU365779) and GD01 (KU740184) both of human origin represented in dark eclipses were
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concern (Chen & Hamer 2016; Fauci & Morens 2016;
Higgs 2016; WHO 2016; CDC 2016). It produces a com-
paratively mild disease in adult humans. As shown in
Figure 4, Zika virus was first isolated from a rhesus
monkey in 1947, at Zika forest in Uganda (Dick et al.
1952; Goma 1965; Derraik & Slaney 2015). Subse-
quently, the second isolation of Zika virus was made
from a batch of wild-caught Aedes africanus in January
1948, in the same forest (Weinbren & Williams 1958;
Haddow et al. 1964). A study conducted in semi-cap-
tive orangutans in Malaysia suggested that these ani-
mals were exposed to Zika virus at some point in time
(Kilbourn et al. 2003). In 1954, during the investigation
of an outbreak of jaundice suspected of being Yellow
Fever in Eastern Nigeria, three cases were confirmed as
positive for Zika virus infection; virus could be isolated
from a serum sample of a 10-year-old girl with a history
of fever and headache only, whereas rise in antibodies
was detected against this virus in two other cases
(MacNamara 1954). During the research on new strains
of Zika virus isolated from A. africanus collected in Zika
forest, one of the researchers became ill with maculo-
papular rash on the face, neck, trunk, and upper arms,
slight malaise with pain in the back and febrile
response and Zika virus could be isolated from a serum
sample while he was febrile (Simpson 1964). Subse-
quently, virus isolation has been made from different
countries including Nigeria (Moore et al. 1975; Fagbami
1979), Ivory Coast in 1999 (Akoua-Koffi et al. 2001),
Cambodia (Heang et al. 2012), Thailand (Buathong
et al. 2015), the Philippines (Alera et al. 2015), Indonesia
(Perkasa et al. 2016), and Brazil (Calvet, Filippis, et al.
2016; Calvet, Aguiar, et al. 2016).
Serological surveys in Africa and Southeast Asia indi-
cated a most likely silent Zika virus circulation with
detection of specific antibodies in various animal spe-
cies (large mammals such as orangutans, zebra, ele-
phants, water buffaloes) and rodents (Geser et al. 1970;
Jan et al. 1978; Lanciotti et al. 2008). However, so far
the natural reservoir for Zika virus is unknown. Further-
more, serosurveys and viral isolation from mosquitoes
and man had confirmed that before 2007, the geo-
graphical distribution of Zika virus was restricted to
tropical Africa and Southeast Asia (Olson et al. 1983;
Martinez-Pulgarin et al. 2016). Of note, in 2007, the first
documented transmission and outbreak of Zika virus
in man (with 185 confirmed cases), outside of its tradi-
tional endemic areas of Africa and Asia, was reported
on Yap Island of the Federated States of Micronesia
(Duffy et al. 2009).
Subsequently, between 2013 and 2015, several dis-
ease outbreaks were notified on islands and archipela-
gos from the Pacific region including a large scale
outbreak in French Polynesia (Hancock et al. 2014;
Musso, Nilles, et al. 2014; European CDC 2014; Attar
2016) and New Caledonia (Cao-Lormeau et al. 2014;
Besnard et al. 2014; Teurlai et al. 2015; Tognarelli et al.
2015). In May 2015, the Pan American Health Organiza-
tion (PAHO) issued an alert after the first confirmed
Zika virus case in Brazil. The emergence of Zika virus in
South America led to a rapid spread throughout South
and Central America, reaching Mexico in November
Figure 4. Landmarks in Zika virus epidemiology. The red area depicts Zika virus presence and/or serological reports (Since
19472016) and in blue denoted serological evidences of Zika in Southeast Asia.
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2015 (Zanluca et al. 2015; WHO 2016). The first case of
Zika virus infection in the USA was recorded recently in
a traveler returning from Latin America to Texas
(McCarthy 2016a). It has appeared sporadically in trav-
elers from the United States of America and Europe
but has not established person-to-person spread in
those areas. As on 30 March 2016, 61 countries and ter-
ritories were reporting local transmission of Zika virus
(Zanluca 2015; Sabogal-Roman et al. 2015; Calvet, Fili-
ppis, et al. 2016; Petersen, , Wilson, et al. 2016; Roa
2016; Fauci & Morens 2016; Gulland 2016a).
In October 2015, Brazil public health authorities
detected an unusual increase in human microcephaly
cases in public and private healthcare facilities in Per-
nambuco state, Northeast Brazil. By 30th March 2016,
6776 suspected cases of microcephaly and/or central
nervous system (CNS) deformations potentially linked
to Zika virus have been reported in Brazil which are
mainly concentrating in Northeastern parts. Further-
more, an increase in GBS has also been observed in
Brazil, Colombia, El Salvador, Martinique, and Suriname
(Campos et al. 2015). Lately, from the United States of
America, locally acquired cases, around 14 in number
without vector-borne transmission, likely to have been
contracted by sexual contact, were reported (Musso,
Roche, Robin, et al. 2015; McCarthy 2016b; McCarthy
2016c), and indirect evidence of local transmission
were further documented in six additional countries
(Lucey & Gostin 2016). There is not a single known case
of someone contracting Zika virus from mosquitoes in
the United States. Very recently in Thailand, a study
showed that seven samples out of 21 tested showed
immunoreactivity to Dengue, Chikungunya, Zika, and
Japanese encephalitis by Western blot. Of note, two
samples reacted only to Zika virus antigen confirming
its presence in Thailand, which marked the first report
of this virus in this part of the world (Wikan et al. 2016).
Japan has also reported Zika virus in urine from a trav-
eler visiting Thailand (Shinohara et al. 2016) and two
earlier cases have been reported in traveler’s returning
from French Polynesia and Japan (Kutsuna et al. 2014).
It was reported in an Australian returning from Indone-
sia. Hence, tourism and travel have also resulted in
transmission of the disease (Kwong et al. 2013).
The geographical distribution of Zika virus has been
steadily increasing since it was first detected in the
Americas in 2015 (Gatherer & Kohl 2016; Hennessey
et al. 2016). It is likely that Zika virus will continue to
spread and will likely reach all countries and territories
of the Americas where Aedes mosquitoes are found. In
less than a year, Zika virus epidemic has evolved in a
WHO-declared global health emergency (Jacob 2016;
Kindhauser 2016). The research community urgently
needs to understand why Zika virus has shifted from
being a virus that caused mild illness to one associated
with more than 4000 suspected microcephaly cases in
Brazil (Petersen, , Wilson, et al. 2016), as well as possibly
GBS (Lucey and Gostin 2016). The WHO has outlined its
$56 million strategic plan to respond to the ongoing
outbreaks of Zika virus disease in the Americas (McCar-
thy 2016d). The plan provides a framework for WHO
and its partner organizations’ Zika response through to
June 2016. Recently, there are four cases of Zika virus
reported from the United Kingdom which may be due
to travel to affected countries (O’Dowd 2016).
The Zika virus-specific antibodies could be detected
from serum samples of six out of 99 residents of
Uganda and one out of 15 wild monkeys tested (Dick
1952). Subsequently, the antibodies against Zika virus
could be detected in man in Nigeria (MacNamara
1952), Uganda, and Tanganyika (United Republic of
Tanzania) (Smithburn 1952). During 19521953, in
India, serum samples have been collected from resi-
dents of 38 localities in 6 states and tested for neutral-
izing antibodies against 15 different arthropod-borne
viruses and a significant number of samples showed
neutralizing activity against Zika virus (Smithburn, Kerr,
Gatne 1954). Subsequently, the presence of antibodies
against Zika virus was reported in several countries 
Malaysia (Smithburn 1954), Borneo (Smithburn 1954),
Vietnam (Pond 1963), Thailand (Smithburn 1954),
Egypt (Smithburn et al. 1954), Philippines (Hammon
et al. 1958), Somalia (Henderson et al. 1968), Kenya
(Geser et al. 1970), Gabon (Jan et al. 1978; Saluzzo et al.
1982), Nigeria (Monath et al. 1973; Fagbami 1977; Fag-
bami 1979; Adekolu-John & Fagbami 1983), Sierra-
Leone (Robin & Mouchet 1975), Indonesia (Olson et al.
1981), Central African Republic (Saluzzo et al. 1981),
Pakistan (Darwish et al. 1983), Senegal (Renaudet et al.
1978; Monlun et al. 1993), Nigeria (Baba et al. 1999),
Côte d’Ivoire (Akoua-Koffi et al. 2001),Yap Island, Feder-
ated States of Micronesia (Lanciotti et al. 2008; Duffy
et al. 2009), Cameroon (Fokam et al. 2010), USA (Foy
et al. 2011), Cambodia (Heang et al. 2012), Zambia
(Babaniyi et al. 2015), and French Polynesia (Aubry
et al. 2015).
In non-human primates, antibodies against Zika
virus have been reported both in wild and experimen-
tal animals in Borneo (Smithburn 1954; Wolfe et al.
2001) and Uganda (Smithburn 1952; Dick 1952; Dick
et al. 1952; Weinbren & Williams 1958; Haddow et al.
1964; Henderson et al. 1968; Henderson et al. 1970;
Kirya & Okia 1977; McCrae & Kirya 1982; Rodhain et al.
1989; Duffy et al. 2009). Since serological cross-reactiv-
ity may occur between Zika virus and other Flaviviruses
(e.g. Dengue, Yellow Fever, St. Louis encephalitis, Japa-
nese encephalitis, West Nile, etc.), molecular assay in
addition to serology such as RT-PCR should be used for
distinguishing these viruses.
Until the large-scale outbreak of Zika virus in 2007 in
the Yap Island (comprises four closely grouped islands
and several outer islands) of the Federated States of
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Micronesia in the North Pacific, 14 cases of human Zika
virus were previously documented (Duffy et al. 2009)
within Africa and Asia. The physicians on Yap Island
noted an outbreak of illness characterized by rash, con-
junctivitis, subjective fever, arthralgia, and arthritis. Ten
out of 71 samples (14%) were confirmed as Zika virus
positive by RT-PCR by CDC, Arbovirus Diagnostic, and
Reference Laboratory in Fort Collins, Colorado, USA.
Further investigation was carried out in the group of
four main islands (total population of 7391 persons).
From a total of 185 suspected cases, 49 (26%) were
confirmed as positive and 59 (32%) classified as proba-
ble (based on a set of criteria mainly by detection of
Zika virus RNA and serology) with an overall morbidity
rate of 14.6 per 1000 Yap Island residents. No deaths or
neurological complications were reported in this out-
break (Lanciotti et al. 2008; Duffy et al. 2009). Analysis
of Zika virus RNA revealed that the outbreak on Yap
Island originated in Southeast Asia (Lanciotti et al.
2008; Duffy et al. 2009; Haddow et al. 2012; Buathong
et al. 2015).
In October 2013, Zika virus outbreak started in
French Polynesia  a French overseas territory located
in the South Pacific. A total of 8510 suspected cases
were reported by the sentinel network from the begin-
ning of the epidemic to 14 February 2014, leading the
estimation at 29,000 (10% of the population), the num-
ber of patients having consulted for a Zika virus infec-
tion. The clinical symptoms observed in this outbreak
were mild Dengue-like illness consisting of low fever
(<38 C), asthenia, wrist and fingers arthralgia, head-
ache, rash, conjunctivitis, swollen ankles, and aphthous
ulcers (Cao-Lormeau et al. 2014). Out of 746 patient
samples, Zika virus RNA was confirmed in 396 (53%) by
RT-PCR, in which 72 cases of severe presentations with
acute neurological symptoms were notified. Among
these, 40 GBS were also diagnosed within three
months (Besnard et al. 2014; European CDC 2014; Cao-
Lormeau et al. 2014; Ioos et al. 2014). The phylogenetic
tree shows that the Zika virus that recently emerged in
French Polynesia is similar to Cambodia 2010 and Yap
State 2007 strains, which suggests an expansion of
Zika virus of Asian lineage (Cao-Lormeau et al. 2014).
The results of retrospective investigations were submit-
ted to WHO. These reports indicate a possible associa-
tion between Zika virus infection and congenital
defects, severe neurological and autoimmune compli-
cations, in particular, an increase in the incidence of
GBS. However, the Island was also experiencing an out-
break of Dengue in association with Zika virus infection
and GBS (Ioos et al. 2014; Kindhauser et al. 2016). Fur-
ther, in 20132014, the outbreak spread to other
Pacific Islands: New Caledonia, Cook Islands, Easter
Island, Vanuatu, and Solomon Islands (Roth et al. 2014;
Cao-Lormeau et al. 2014; Musso, Nhan, et al. 2014).
The first autochthonous cases of Zika virus in Brazil
(in the city of Natal, state of Rio Grande do Norte) was
confirmed in May 2015. In the year 2015, a total of Zika
virus cases in Brazil amounted to the tune of
440,0001,300,000, along with 4783 cases of microen-
cephaly, where 76 were associated with mortality in
the northeast province of Brazil (Heukelbach et al.
2016). Symptoms observed in these cases were arthral-
gia, oedema of extremities, mild fever, maculopapular
rashes frequently pruritic, headaches, retro-orbital
pain, no purulent conjunctivitis, vertigo, myalgia, and
digestive disorders. Eight out of 21 samples were posi-
tive for Zika virus RNA and shared a high nucleic acid
identity with sequences from the Zika virus of Asian
lineage (Zanluca et al. 2015). Since then, cases of Zika
virus are being continuously reported from several
states. The major concern is a several fold increase in
infants with microcephaly after the introduction of the
Zika virus into Brazil. Before 2015, the annual reported
cases of microcephaly were consistently below 200
whereas the number of suspected cases reported
between November 2015 and 13 February 2016 was
5280. In the initial screening of 1345 samples, Zika virus
was detected in 41 samples (Victora et al. 2016) (http://
apps.who.int/iris/bitstream/10665/204454/1/zikasitrep_
19Feb2016_eng.pdf?ua D 1). Between 1 January
2007 and 17 February 2016, a total of 48 countries
and territories reported local (autochthonous) trans-
mission of Zika virus (http://apps.who.int/iris/bit
stream/10665/204454/1/ zikasitrep_19Feb 2016_en
g.pdf?ua D 1).
The Zika virus transmission can be classified into
vector-borne and non-vector-borne. In the vector-
borne mode, several species of the genus Aedes are
involved. The non-vector-borne mode includes sexual
transmission, blood transfusion, perinatal or intra-uter-
ine transmission, postnatal transmission, and animal
bites (Pati~no-Barbosa et al. 2015).
Zika virus is maintained in the community through
its  (1) sylvatic cycle, where the virus circulates
between non-human primates and Aedes mosquitoes,
(2) urban cycle, where the virus circulates between
man and domestic mosquitoes. Till the year 2007, the
most known facts about zika outbreaks demonstrate
sylvatic origin/cycle (Weaver et al. 2016). The primary
mode of transmission of vector-borne Zika virus is
through the bites of female mosquitoes in the Aedes
genus. The main species in the Zika virus mosquito
transmission is Aedes aegypti and there are at least 20
other species that have been tested positive to Zika
virus including Aedes albopictus, A. africanus, Aedes
luteocephalus, Aedes vitattus, Aedes furcifer, Aedes hensi-
lii, Aedes apicoargenteus, Aedes. polynesiensis, A. dalzieli,
Aedes hirsutus, Aedes metalicus, Aedes taylori, Aedes uni-
lineatus, A. apicoargenteus, Anopheles coustani, Culex
perfuscus, and Mansonia uniformis (MacNamara 1952;
Dick et al. 1952; Dick 1953; MacNamara 1954; Weinbren
& Williams 1958; Haddow et al. 1964; Simpson 1964;
Fagbami 1979; Haddow et al. 2012; Petersen, Wilson,
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et al. 2016; Zanluca & dos Santos 2016; Li et al. 2016).
Male mosquitoes live only for 10 days while female
mosquitoes live for one to two months suggesting that
female mosquitoes have a role in transmission and har-
bouring of the virus (Chang et al. 2016). Since the Aedes
mosquitoes are found in many parts of the world, it is
likely that outbreaks of Zika virus might spread to new
na€ıve areas (Petersen, Wilson, et al. 2016). Transmission
potential of Zika virus was found to be similar to Den-
gue and Chikungunya since mosquito is mainly
involved in all three diseases (Nishiura et al. 2016).
Recently, in Senegal mosquito species like A. unilinea-
tus, A. vittatus, and A. luteocephalus were studied for
their vector competence and it was found that all spe-
cies were susceptible to infection by oral route (Diagne
et al. 2015). A study in Yap Island revealed that A. hen-
silli was the most important vector for transmission of
Zika virus and Chikungunya (Ledermann et al. 2014).
Similarly, a study from Singapore reports that A. Stego-
myia is the potential vector for Zika virus transmission
(Li et al. 2012).
In August 2008, two American scientists who worked
in the village of Bandafassi in southeastern Senegal
while performing a mosquito-sampling project in sur-
rounding villages, after returning to the USA, showed
Zika-like clinical illness within a week. Furthermore, the
wife of one of the above researchers also showed clini-
cal signs but she never traveled to Africa or Asia and
had not left the United States of America since 2007.
The Zika virus infection was confirmed by a serological
assay. Circumstantial evidence suggests direct person-
to-person, possibly sexual, transmission of the virus (Foy
et al. 2011). In December 2013, during a Zika virus out-
break in French Polynesia, a patient in Tahiti sought
treatment for hematospermia, and replicative Zika virus
could be detected from semen samples (Musso, Roche,
Robin, et al. 2015). Sexual transmission of Zika virus is
not assumed to be a major factor in its spread. Over
80% of Zika virus infection is silent in persons without
overt clinical signs including blood donors. Blood-borne
transmission of Zika virus via blood transfusion is a
major concern (Marano et al. 2015; Petersen, Wilson,
et al. 2016). From November 2013 to February 2014, 42
(3%) of 1505 blood donors, although asymptomatic at
the time of blood donation, were found positive for
Zika virus by PCR (Musso, Nhan, et al. 2014).
During Zika virus outbreak in French Polynesia, two
mothers and their newborns had detectable Zika virus
RNA in serum collected within four days post-delivery
by RT-PCR. The infants’ infection most probably
occurred by transplacental transmission or during
delivery (Besnard et al. 2014). Zika virus RNA could be
detected from some of the microcephaly samples (Mla-
kar et al. 2016; Rubin et al. 2016) and from amniotic
fluid of two pregnant women with microcephaly
fetuses in Brazil (Calvet, Aguiar, et al. 2016). In the latter
study, the virus could be isolated. The other plausible
mode of transmission is monkey bite (Leung et al.
2015). Serological studies reveal that Zika antibodies
can be detected in goats, sheep, bats, and rodents.
Serosurvey studies have detected antibodies to Zika
virus in bats, goats, and rodents of the species Bandi-
cota bengalensis, Tatera indica, and Meriones hurrianae,
but such serological data may be misleading since
there is cross reaction between flaviviruses, however
it cannot be excluded (Musso & Gubler, 2016).
Hence, there is no well-documented reservoir animal




Zika virus has an incubation period of 312 days
(Burke et al. 2016; Goeijenbier et al. 2016). Clinical signs
include acute fever, maculopapular skin rashes, non-
purulent conjunctivitis, arthralgia, headache, myalgia,
asthenia, edema of hand and feet and less evident
signs like anorexia, abdominal pain, vomiting, diar-
rrhoea, vertigo, burning sensation of sole and palm
and at times there may be pain in the retro orbital
region, and pruritits (Korhonen et al. 2016; Shinohara
et al. 2016; Zammarchi, Stella, et al. 2015; Zammarchi,
Tappe, et al. 2015; Basarab et al. 2016; Goeijenbier
et al. 2016). Symptomps are usually self-limiting and
may last for four to seven days (Barrera-Cruz et al.
2016). Haematuria and haematospermia (there is no
report of haematospermia caused by other arbovi-
ruses) have been documented in some cases (Foy et al.
2011; Musso, Roche, Robin, et al. 2015). These clinical
signs are overlapping with the clinical findings of Den-
gue and Chikungunya, but Zika virus-induced symp-
toms are milder than those of others (Carneiro &
Travassos 2016; Tappe et al. 2016). Abrupt onset of
fever and appearance of rashes, often pruritic which
disappear quickly with time, are characteristic features.
Occasionally, Zika virus may cause nerve-associated
abnormalities tentatively referred to as GBS (Oehler
et al. 2014; Gatherer & Kohl 2016; Pinto et al. 2015).
Infected pregnant woman traveling to an area where
Zika virus outbreak has recently occurred should be
routinely subjected to ultrasound to assess the abnor-
mal cranial development of the fetus (Schuler-Faccini
et al. 2016; Dyer 2015; Dyer, 2016b; McCarthy 2016e). If
the infants are getting an infection from their mother
in utero, the virus has been reported to be a reason for
the foetal abnormalities like microcephaly, intracra-
nial calcification, hydrops fetalis, hydranencephaly, and
eye abnormalities mainly affecting macular and optic
nerve development (McCarthy 2016f; Sarno et al.,
2016; Vest 2016). A study reported 29% of the 42 preg-
nant women infected with Zika virus had fetal abnor-
malities revealed ultrasonically and 12% of the
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examined womens foetus had microcephaly, cerebral
atrophy, and brain calcifications (Driggers et al. 2016).
There was no adverse effect seen on retinal develop-
ment in such infants (Ventura, Maia, Bravo-Filho, et al.
2016; Schuler-Faccini et al. 2016; Ventura, Maia, Ven-
tura, et al. 2016). In the case of no cranial abnormalities
in infants born from infected mothers, they need to be
checked during the first year of life routinely by peri-
odic cranial ultrasound, routine eye checkup, and hear-
ing tests to diagnose subclinical cases (Staples et al.
2016). Microcephaly has been reported mainly from
Latin American countries though Africa and Asia are
endemic and the hypothesis suggested was that
women exposed to zika virus at early age gain immu-
nity against zika hence may resist fetal anomalies
(Frank et al. 2016). Recently, hypertensive iridocyclitis
in Zika virus infection has been reported (Fontes 2016).
An ocular abnormality has been noticed which include
chorioretinal atrophy and also gross pigment mottling
as well as hypoplasia of the optic nerve (Ventura, Maia,
Ventura, et al. 2016). Co-infection with Zika virus, Chi-
kungunya, and Dengue virus has been reported in
Colombia (Faccini-Martınez et al. 2016; Villamil-Gomez
et al. 2016). An overview of Zika viral disease is pre-
sented in Figure 5.
6.2. Pathology and pathogenesis
Zika virus isolates from French Polynesia exhibited
their affinity towards human immature dendritic cells,
dermal fibroblasts, and epidermal keratinocytes. Zika
virus may replicate in the midgut when Aedes mosqui-
toes feed blood meal as like other flaviviruses and later
in the salivary glands. Vertical transmission of Zika virus
by transovarian route also cannot be excluded (Chan
et al. 2016). Aedes mosquito injects Zika virus while
feeding on man and the virus enters the cells through
receptors like AXL, DC-SIGN, Tyro3 and Tim-1 (lesser
extent) that are found on the surface of both skin and
nerve cells (Hamel et al. 2015). Inside the cells, they use
host machinery and finally cause apoptosis and
autophagy of the cells thereby entering other cells.
Zika virus stimulates transcription of TLR-3, MDA5,
RIG-I, and also interferon genes like OAS2, ISG15, and
MX1. Viral replication in the cells causes the release of
type I interferon (Hamel et al. 2015). Replication of Zika
virus is increased by inducing autophagy in the host.
Thus, agents inhibiting autophagy can decrease virus
load in the cells (Carneiro & Travassos 2016). After
replication locally, virus gets distributed to muscles,
heart, CNS, and also to foetus by crossing the
Figure 5. An overview of Zika viral disease and its prevention and control.
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placental barrier through blood vessels and lymphatics
(Chan et al. 2016). The damage in the eye of infants is
presumed to be due to Zika virus infection and needs
further detailed pathophysiological investigations
(McCarthy 2016f). Zika virus might have evolved cer-
tain means to defeat the defence of the trophoblast
thereby attacking neuronal tissues causing neuronal
abnormalities in the fetus (Sadovsky et al. 2016).
In earlier reports, Zika virus had been shown to have
affinity towards brain cells which was demonstrated
with the aid of intraperitoneal injection of mice that
showed that Zika virus can cross the bloodbrain bar-
rier (Dick 1952). Neurons and glial cells were infected
by virus producing intracytoplasmic inclusions called
viral factories having their origin from the endoplasmic
reticulum and also from mitochondria and nucleus
(Bell et al. 1971). Recent studies indicate that Zika virus
can infect neuroblast cells in-vivo (Tang et al. 2016).
Autophagy, as noticed in the dermal fibroblast cells is
not noticed in the neurons. Microcephaly has been
proposed to be due to abnormalities in the centro-
somes yet several studies need to be conducted before
confirmation (Tetro 2016). There was enlargement of
astrocytes and there was also the destruction of hippo-
campus especially regarding pyriform cells (Bell et al.
1971). Inflammatory responses of the placenta due to
Zika virus can also cause damage to the fetus (Mor
2016). Transient leukopenia and thrombocytopenia
have been reported in few cases. Serum biochemistry
shows that there may or may not be an increase in
aspartate aminotransferase (AST) and alanine amino-
transferase (ALT) activities (Tappe et al. 2014).
6.3. Immunobiology and immunity
Antibody-dependent enhancement (ADE) of infec-
tion is common among Dengue virus serotypes. The
recent outbreak of Zika virus has caused more panic
than earlier outbreaks and one reason that can be
related is that most of the recent outbreaks
occurred in hyper-endemic regions of Dengue virus.
ADE may be a reason where antibody raised against
Dengue virus might have caused enhancement of
Zika infection (Lazear & Diamond 2016). Immunity
against re-infection develops for an unidentified
time period (Tappe et al. 2015). The increase in che-
mokines is shown at a higher level than cytokines
in Zika viral disease and cytokines level declined
during the recovery phase. During acute disease,
there is a rise in IL-2, IFN-g , IL- 4, IL-13, IL-17, and
IL-9 (Tappe et al. 2015). Regulated on Activation,
Normal T Cell Expressed and Secreted (RANTES) or
CCL5 was elevated in the acute phase of disease
while IP-10 was elevated in the later recovery phase
(Tappe et al. 2015). Further studies are needed to
elucidate the immune response of host against Zika
virus disease. Recently, a study revealed that Zika
virus and man have a peptide in common, hence
this may be the reason for microcephaly and GBS
(Lucchese & Kanduc, 2016).
7. Public health importance
Zika virus disease has been a major threat throughout
the world, but it has shown its hideous face in Brazil. It
is not only Zika virus but also Dengue and Chikungu-
nya that have caused damage in Brazil. A recent report
shows that there is co-infection of Zika, Dengue, and
Chickungunya in Pernambuco, Brazil (Pessôa et al.
2016). This has kindled interest among researchers
why these diseases affect mainly this part of the world.
The study shows that it was mainly due to climate
change causing an alteration in the vector population
(Gautret & Simon 2016). Crowding at a particular place
due to meetings like World cup, Olympics, etc. could
also aid in transmission of diseases. Good knowledge
about the diseases prevailing in the native population
should be identified and they should be segregated so
as to prevent transmission to the tourists. Arboviral dis-
eases like Dengue, Chikungunya, and recently, Zika
have created panic amongst tourists who planned to
visit countries like Brazil where disease threat is more
predominant (Gautret & Simon 2016). FIFA world cup
was held in Brazil in the year 2014 and several studies
were conducted to assess the arboviral diseases influ-
enced by it and it was found that four to nine people
out of 100,000 tourists who visited Brazil succumbed
to Dengue (van Panhuis et al. 2014). Some researchers
are also of the opinion that Zika virus has also entered
during FIFA world cup 2014 into Brazil, but there is no
evidence to support this speculation (Zanluca et al.
2015). Another major sports event took place later in
August 2014 named as ‘Va’a World Sprint Champion-
ship canoe race’ where there were participants from
French Polynesia, New Caledonia, Cook Islands, and
Easter Islands, hence this was also speculated for the
reason of disease introduction into Brazil. Hypothesis
and possibilities were made that people from Chile has
transmitted this disease to Brazil during this event (Sal-
vador & Fujita 2015). It was speculated that Zika virus
might have entered northeast of Brazil through Natal,
Recife, Salvador, and Fortaleza where the 2014 World
cup football took place. Phylogenetic analysis by
researchers revealed that Zika virus might have been
introduced in the year 2013 around May to December.
By the end of 2015, Zika virus has spread the entire
length of Brazil (Weaver et al. 2016). Summer Olympics
2016 is around the corner and Zika virus has pressed
the alarm button on all health and sports officials in
Brazil to look after the health issues of athletes travel-
ing from different parts of the world (Citrome 2016).
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8. Diagnosis, surveillance and monitoring
Zika virus infection can be diagnosed based upon clini-
cal symptoms, the prevalence of vector in the region,
and by serological and molecular detection assays. The
isolation of Zika virus from mosquito samples was car-
ried out using newborn Swiss albino mice through dif-
ferent routes like intraperitoneal, intracerebral, and
subcutaneous injections (Marchette et al. 1969; Way
et al. 1976). Passages from brain material revealed Zika
virus which was further confirmed using hemaggluti-
nation inhibition test (Haddow et al. 1964). Zika virus
can be cultivated in cell lines like Vero cells, rhesus
monkey kidney cells like LLC- 192 MK2, and cell lines of
mosquito origin like A. albopictus (C6/36) and A. psue-
doscutellaris (MOS61 or AP-61) (Waggoner & Pinsky
2016). Vero and Vero E6 cells were used for isolation of
Zika from saliva (Barzon et al. 2016). Recently, a murine
model for studying Zika virus has also been reported
which could aid in understanding the disease pattern
(Rossi et al. 2016). Haemagglutination inhibition test,
serum neutralization test, and complement fixation
tests have been employed for the diagnosis of Zika
virus disease (Fagbami 1979; Monath et al. 1980). The
serological diagnosis involves detection of IgG and IgM
antibodies. For detecting antibodies against Zika virus
in serum of patients, IgM antibodies can be monitored
by ELISA. It is positive if Zika virus neutralizing antibody
titre is higher than fourfold from Dengue neutralizing
antibodies, else the test is considered to be inconclu-
sive (Staples et al. 2016). Cross reaction between other
members of the flavirus hinders the use of ELISA tech-
niques and hence plaque reduction neutralization test
(PRNT) can be done to identify Zika virus induced anti-
bodies (Petersen, Jamieson, et al. 2016). PRNT helps in
distinguishing cross-neutralizing antibodies generated
by various Flaviviruses (Staples et al. 2016). Seroconver-
sion is confirmed by analyzing IgM and IgG titres in
paired serum samples from the acute and convalescent
phase of infection (Pyke et al. 2014). Earlier haemagglu-
tination inhibition and mouse protection tests were
also used to detect Zika virus antibodies in serum (Fag-
bami 1979; Kirya & Okia 1977).
Microcephaly is detected by measuring occipitofron-
tal circumference as suggested by standard charts (WHO
2006). Ultrasound scanning can be employed for detec-
tion of microcephaly in pregnant women (SMFM Publica-
tions Committee 2016; Oliveira et al. 2016). Several foetal
abnormalities can be identified around five months of
gestation, but microcephaly can only be identified
around fix toseven months of gestation or after birth
(Lazear et al. 2016). Further confirmation can be done
using molecular and serological tests (Staples et al. 2016).
Blood picture reveals neutropenia and thrombocy-
topenia (Rafiei et al. 2016). Molecular diagnosis
involves detecting RNA of Zika virus by RT-PCR. In the
initial phase of the disease (first seven days) viral
nucleic acids can be detected in the serum (Haug et al.
2016). Sample involves serum of patients or umbilical
cord sample of infants, urine, nasopharyngeal swab,
saliva, amniotic fluid, CSF, and frozen and fixed pla-
centa (Staples et al. 2016; Shinohara et al. 2016;
Tognarelli et al. 2015; Leung et al. 2015; Musso, Roche,
Nhan, et al. 2015; Gourinat et al. 2015; Balm et al. 2012;
de M Campos et al. 2016). Shedding of virus in different
body fluids like urine (persists for 1520 days) has to
be elucidated to establish a better diagnostic assay
combined with exact sample of choice (Moulin et al.
2016). A report suggests that viruria can be seen more
than 15 days after the onset of symptomps (Roze et al.
2016). Recently, in order to establish the relationship
between Zika virus and microcephaly, scientists started
to investigate antibodies against Zika virus in amniotic
fluid and also in the blood of neonates (Jacob 2016).
RT-PCR followed by DNA sequencing is considered
confirmatory (Zanluca et al. 2015). Further sequencing
of NS5, NS3, and envelope gene confirms the relation
of various strains of Zika virus (Tognarelli et al. 2015;
Fonseca et al. 2014; Grard et al. 2014). Real-time PCR
(rRT-PCR) can be employed to detect the virus in the
early stage of infection (Faye et al. 2013; Faye et al.
2008). Furthermore, it can be confirmed by employing
immunohistochemical staining of antigen fixed on the
umbilical cord and placenta of infected infants (Staples
et al. 2016).
The rapid spread of the Zika virus and its epidemic
potential along with the presence of other arboviruses
create difficulties in the differential diagnosis (Pinto
et al. 2015). Till now, no commercial diagnostic tests
exist for diagnosing this viral infection. Advances in
diagnostic techniques need to be applied for Zika virus
detection viz., multiplex PCR, LAMP, recombinant diag-
nostics, gene sequencing and phylogenetic analysis,
biosensors, biochips, microarrays, and nanotechnology-
based diagnostics (Jain 2007; Kawadkar et al. 2011;
Dhama, Karthik, et al. 2014; Ratcliff et al. 2007; Bergquist
2011; Van den Hurk and Evoy 2015). Apart from these
newer tools for extensive epidemiological and surveil-
lance studies, alternatives need to be explored for track-
ing and monitoring Zika virus infections and spread,
such as geographical information system and establish-
ing networking programs to counter this important
pathogen. More recently, a mobile App named as ZIKA-
Tracker (zikatracker.net) has been developed in four lan-
guages to report the cases as they occur so that they
can be effectively controlled and provided on time
(Kelvin et al., 2016). Such early reporting helps in under-
standing the pattern of spread of the disease from one
area to another. It is essential to use such techniques to
report Zika virus cases at earliest possibility keeping in
mind the rapid spread of the virus (Nishiura et al. 2016).
All developments and timely progress would help in
rapid detection of Zika virus and design effective dis-
ease prevention and control programmes.
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9. Prevention and control strategies
Prevention and control of Zika virus are mainly aimed
at prevention of vector population (mosquitoes) as
they play an important role in the transmission of this
virus (Ahmad et al. 2016). Control measures are similar
to the measures adopted for Dengue and Chikungunya
viruses that are also transmitted by vectors (Pinto et al.
2015). Mosquito of the genus Aedes is the vector trans-
mitting Zika virus and also another important vector-
borne disease namely Dengue (Araujo et al. 2015).
Hence, control of vector population is of prime impor-
tance to control the transmission of these important
dreadful diseases among humans. Day-time avoidance
of the mosquito bites from infected patients can
reduce a human-to-mosquito transmission thereby
preventing transmission to other humans. These vec-
tors can be controlled either by mechanical, chemical,
and biological measures (Araujo et al. 2015).
Mechanical control methods involve removal of any
objects that can aid in unwanted storage of water in
the premises that serve as a breeding point for female
mosquitoes. Removal of those objects like plastic bags,
unused tyres, unused containers, bottles, and also clos-
ing water tanks with lids can prevent breeding areas of
the mosquitoes (Araujo et al. 2015). Chemical control
of insects and vectors is an age-old technique and can
be used with caution as it can cause toxicity to animals
(Dick et al. 2012). Recently, chemicals like pyrethroids,
organochloride, and organophosphorus which acts on
the nervous system of the vectors are being used to
prevent mosquitoes. The major disadvantage in the
use of these chemicals is the problem of resistance
development and also these compounds are toxic to
higher mammals thereby questioning its use for the
control of vectors (CDC 2012). Preparations like N,N-
diethyl-meta-toluamide (DEET) and picaridin insect
repellent can be used as they are safe for pregnant
women (Kline & Schutze 2016). Herbal therapy has not
only been revolutionizing as an antimicrobial regimen
but also has been implemented recently in the control
of vectors. These botanical insecticides can be pro-
duced from leaves, seeds, and even fruits of different
plant varieties (Ghosh et al. 2012). Some of the plants
that can be used for extraction of botanical insecticides
include Apium graveolens, Callistemon rigidus, Cipa-
dessa baccifera, and Persea Americana (Kumar et al.
2014; Pierre et al. 2014). Extracts can be isolated from
these plants and can be employed to find the cidal
action against larvae and other stages of the mosqui-
toes so that it can be employed as a safe insecticide
(Dias et al. 2014). These extracts can also be used as a
repellent in the household day-to-day to effectively
control mosquito bites so that prevention of deadly
diseases like Zika virus becomes easy (Ramkumar &
Karthi 2015). Cymbopogon citratus and Eucalyptus cit-
riodora possess a principle named Citronella which has
been used in mosquito repellents these days. Another
study also reported Apium graveolens seed oil has a
good repelling power against Aedes mosquito (Kumar
et al. 2014). Biological control of vectors might also
involve the use of bacteria namely Bacillus thuringiensis
israelensis producing deadly endotoxins when mosqui-
toes ingest those bacteria (Boyce et al. 2013). Fungi
like Beauveria bassiana has also been used to control
Aedes mosquitoes (Darbro et al. 2012). Another
approach is the use of larvivorous fishes (e.g. Gambusia
affinis) in the water-logging areas and flower pots
which can eliminate larvae of mosquitoes (Kant et al.
2013).
Lately, the use of microbes to control vector popula-
tion gained interest and certain genus of bacteria
named Asaia has been explored for its ability to colo-
nize the gut and reproductive tract of mosquitoes and
also to get transmitted vertically to its progeny (Favia
et al. 2008). Another bacterium named Wolbachia has
the potential to feminize male vectors thereby pre-
venting the reproduction of vectors hence controlling
their population (Brelsfoard & Dobson 2009). Trails are
on the way using this bacterium and sterile males have
been released into the environment to monitor
the effect on reproduction (Frentiu et al. 2014). Trails
are conducted in Australia, Vietnam, Indonesia, and
also in Brazil using these sterile males created by the
use of Wolbachia (Blagrove et al. 2012). Wolbachia-
infected mosquitoes need to be realesed over a wide
geographical area as the A. aegypti has a poor flight
range and also, it can evolve mechanisms to resist Wol-
bachia (Weaver et al. 2016). Other techniques like irra-
diation have been carried out to generate sterile males
to control the mosquito population (Alphey 2014).
Genetic modification of mosquitoes is another
approach that can be used to control its population by
interrupting their reproduction. Two different
approaches can be adopted to achieve this as (1)
suppression or complete eradication of the vectors
with the aid of genes that can kill the vector or make
them sterile and (2) substitution method where a con-
structed gene will prevent the transmission of disease
(Reis-Castro 2012; Carvalho et al. 2014). The approach
of using sterile male is not new since it is an age-old
approach which has successfully aided in local control
of certain vectors like Cochliomyia hominivorax (New
World screwworm fly) in the United States of America,
Central America, and Mexico, the Ceratitis capitata
(Mediterranean fruit fly) and Pectinophora gossypiella
(pink bollworm) in the United States of America, Cydia
pomonella (codling moth) in Canada and Glossina fus-
cipes (tsetse fly) in Zanzibar (Alphey et al. 2010; Burt
2014). Use of gamma irradiation that can damage the
DNA leading to mutation has been the theme of sterile
male techniques (Alphey 2014). Use of sterile male
mosquitoes of A. aegypti in the Grand Cayman (first
experiment of its kind) resulted in around 80%
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reduction in the population of wild mosquito (Harris
et al. 2012). Oxitec released in a trial in Piracicaba,
Brazil, an engineered mosquitoe with ‘self-limiting’
gene that halts the reproduction of other mosquitoes
by not allowing their offsprings to develope into adult
mosquitoes, revealed 82% larval reduction during last
year (Al-Qahtani et al. 2016).
Apart from vector control, proper surveillance and
monitoring has to be carried out at the highest level in
countries where there are reports and also countries
adjoining them. Strict biosecurity measures need to be
ensured so that disease transmission can be kept
under check (Musso & Nhan 2015). All international air-
ports, harbors, and places of international tourist
attraction is needed to be under the scanner for the
screening of this important disease. Especially preg-
nant woman should be advised not to travel to coun-
tries under threat of Zika viral disease and is advised to
avoid travel to areas below 2000 m of sea level since a
study reported that mosquito-borne Zika viral infection
is possible above 2000 m (Petersen et al. 2016c; Cetron
2016). Several guidelines have been issued periodically
by CDC and other health departments regarding do’s
and dont’s during an outbreak (Oster et al. 2016;
Ahmad et al. 2016; Fleming-Dutra 2016) and need to
be strictly followed. Since sexual transmission has been
reported recently in humans, guidelines have been
issued to both men and women that have to be
adopted to prevent further spread. These guidelines
include: (1) men returning from an area of Zika disease
should avoid or have safe sex with partner (Oster et al.
2016), and (2) a recent study also reports that Zika virus
has been detected in semen though it could not be
detected in blood hence men who traveled to coun-
tries under disease outbreak or who had been bitten
by Aedes mosquitoes should be screened since cases
are mostly (80%) asymptomatic (Musso, Roche, Robin,
et al. 2015). Summer Olympics 2016 is around the cor-
ner hence thorough surveillance is needed as Brazil is
worst hit by this virus so as to prevent further damage
to the human population (Bogoch et al. 2016). An over-
view of prevention and control of Zika virus is pre-
sented in Figure 5.
10. Vaccines
Vaccines are not yet available to counter the Zika virus
infection (Borchardt 2016). The development of Zika
virus vaccine requires a long time-line process. Only
after the recent emergence and high public health
concerns associated with this virus, efforts are being
made towards developing a vaccine which could be in
production by this year end (Dyer 2016a; O’Dowd
2016). As a front-runner in the race for a Zika virus vac-
cine development, this perspective Zika virus vaccine
could easily be produced to very high levels in a short
time period, and could meet the demand to some
extent of any sudden emergency appearing in future.
Around 23 groups from different countries are working
on the development of vaccine against Zika (Gulland
2016c). Approaches employed for the development of
vaccine against three Flaviviruses (Yellow fever virus,
Japanses encephalitis virus, and tick-borne encephalitis
virus) can be used for zika vaccine development. An
ideal Zika virus vaccine should have important qualities
like administration of a single dose vaccination protect-
ing from Zika viral disease, a safe vaccine which can be
used in pregnancy, and rendering long lasting immu-
nity (Palacios et al. 2016). Apart from conventional vac-
cines (live attenuated or inactivated), newer and
advanced technologies of vaccine development need
to be explored to their full potential for developing
effective vaccine against Zika virus such as DNA vac-
cines, subunit vaccines, recombinant vaccines, vec-
tored vaccines, transgenic plant vaccines, reverse
vaccinology, viruslike particles, gene/mutantde-
leted vaccines, nanovaccines, and adjuvanted vaccines
which are showing promising results for countering
various infectious pathogens (Petrovsky and Aguilar
2004; Dhama, et al. 2008; Dhama, Wani, et al. 2013;
Delany et al. 2014; Finco and Rappuoli 2014; Kim et al.
2014; Reed et al. 2013; Singh et al. 2015; Zhou et al.
2014; Pany et al. 2015; Ulmer et al. 2015). A futuristic
perspective needs to have a better understanding of
the immune mechanisms, immunobiology, pathogene-
sis and molecular characterization of Zika virus, neces-
sary modifications of vaccine components with
immunogenic antigens, and incorporating modern
adjuvants such as TLRs, improving the vaccine delivery
systems and appropriate immunomodulatory
approaches.
11. Treatment
Currently, there is no antiviral drug that can save the
human population against potential pandemic threats
of Zika virus. Only supportive treatment is in use for
Zika virus disease like rest, use of fluids, and analgesics
to reduce pain and antipyretics to reduce fever
(Petersen et al. 2016c). Very recently, there is a report
from China on the use of Xiyanping injection com-
bined with supportive therapy with promising results
(Deng et al. 2016). Xiyanping is a semi-synthetic com-
ponent extracted from Andrographis paniculata, a Chi-
nese herb (Xiao et al. 2013). The chemical component
present in Xiyanping is 9-dehydro-17-hydro-androgra-
pholide and sodium 9-dehydro-17-hydro-androgra-
pholide-19-yl sulfate and possesses anti-inflammatory
and antiviral activity (Chong et al. 2013). Antipyretics-
like acetaminophen or dipyrone can be used to reduce
fever, while aspirin should be avoided to reduce hem-
orrhages until confirmation of Dengue (Rasmussen
et al. 2011; Petersen, Staples, et al. 2016). Although
aspirin and other non-steroidal anti-inflammatory
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drugs are not typically used in pregnancy, these medi-
cations should specifically be avoided until Dengue is
ruled out (Petersen, Staples, et al. 2016). Pregnant
women with confirmed Zika viral disease should regu-
larly have a check up of the fetus to assess its health
(Petersen, Staples, et al. 2016). Review of the literature
reveals that upcoming and emerging therapeutic regi-
mens have not been explored yet for possibilities to
treat Zika viral disease, as have been studied recently
with other infectious pathogens and are showing
promising therapeutic values for treating various dis-
eases including viral diseases. Like for countering
recent pandemic threats of flu viruses (bird flu and
swine flu), Tamiflu was developed and similarly for
Ebola virus emergency ZMapp (humanized mouse anti-
bodies) was developed. There is also a dire need to find
out the suitable antiviral drug for prevention and con-
trol of Zika virus. Hence, seeing the public health signif-
icance of this virus and global concerns, research
needs immediate attention to exploit valuable thera-
peutic options of novel and emerging/upcoming regi-
mens such as cytokines, RNA polymerase inhibitors,
microRNA (mi-RNAs), small interfering RNA (si-RNA),
avian egg yolk antibodies (IgY), phages, toll-like recep-
tors (TLRs), probiotics, herbs/plant extracts, nutritional
immunomodulation, immunotherapeutic, and nano-
technology-based treatments along with attempting
for drug discovery and developments (Blecher et al.
2011; Kawadkar et al. 2011; Dhama, Chakraborty, et al.
2013; Dhama,,Chakraborty, et al. 2014; Dhama, Samina-
than, et al. 2015; Mahima et al. 2012; Malik et al. 2013;
Junquera et al. 2014; Tiwari et al. 2014). For this pur-
pose, much research and clinical trials are required to
find a suitable and/or novel therapeutic to treat and
control the disease
12. Conclusion and future prospectives
A few years back, Zika virus was thought to be innocu-
ous but since its emergence into pandemic status, now
the researchers are searching globally for a solution to
stop its spread. The main mode of transmission of Zika
virus is mosquito species (Aedes), which is also serving
as a vector for other related Flaviviruses such as Den-
gue and Chikungunya. Although Zika virus is currently
a concern in Western Hemisphere, it may not take the
time to reach the remaining parts of the world, due to
its vector and rapid movement of the human popula-
tion globally. Though there are also other modes of
virus transmission such as intrauterine, sexual inter-
course, and blood transfusion, priority should be given
to the mosquito control. For example, the use of Wol-
bachia pipientis  a common bacterium that infects
mosquitoes as well as genetically modified mosquitoes
 may reduce the spread of these viruses. However,
much research needs to assess their effectiveness and
safety. Since the pathogenic potential of Zika virus is
comparatively new, not much information is available
regarding its genetic characterization which is most
important in understanding  why the virus became
virulent?, What kind of mutation is involved regarding
its virulence?, What are molecular differences between
mosquito, mice, and human adopted by viruses? The
other areas of interest are hostpathogen interaction
studies which will provide the answers to how the
viruses are crossing the placental barrier? Why it causes
microcephaly and/or neurological disorders? Why is
the Brazilian population more susceptible to Zika virus
infection especially regarding fetal abnormalities? As
the currently available serological assays including
neutralization assay are cross-reactive with other
related Flaviviruses such as Yellow Fever, Dengue, and
Chikungunya, a subsequent confirmatory test is neces-
sary. Therefore, identifying the unique portion of Zika
virus genome and developing recombinant-based
diagnostic assays are in immediate need. Abortion has
been banned in many countries of the world, hence
strict precautionary measures needs to be undertaken
by the pregnant women residing in the countries with
Zika virus disease so as to prevent damage to the foe-
tus. Currently, there is no vaccine available and scien-
tists should focus on isolation and development of
vaccine on war foot basis. Currently, detailed epidemi-
ological data are scarcly available and these should be
extended, including developing countries, to be able
to determine the true prevalence of the virus and dis-
ease manifestations within their borders. Can domestic
animals get infected with Zika virus?  the veterinary
community should think about it and start the research
immediately. Finally, researchers and policy-makers
should be generous enough to share their data
between researchers/countries.
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Pessôa R, Patriota JV, Lourdes de Souza Md, Felix AC,
Mamede N, Sanabani SS. 2016. Investigation into an out-
break of Dengue-like illness in Pernambuco, Brazil,
revealed a cocirculation of Zika, Chikungunya, and Den-
gue virus Type 1. Medicine (Baltimore). 95:e3201.
doi:10.1097/MD.0000000000003201
Petersen E, Wilson ME, Touch S, McCloskey B, Mwaba P, Bates
M, Dar O, Mattes F, Kidd M, Ippolito G, et al. 2016. Rapid
spread of Zika virus in the Americas - implications for pub-
lic health preparedness for mass gatherings at the 2016
Brazil Olympic Games. Int J Infect Dis. 44:1115.
Petersen EE, Staples JE, Meaney-Delman D, Fischer M, Elling-
ton SR, Callaghan WM, Jamieson DJ. 2016. Interim guide-
lines for pregnant women during a Zika virus outbreak 
United States, 2016. MMWR Morb Mortal Wkly Rep.
65:3033.
Petersen LR, Jamieson DJ, Powers AM, Honein MA. 2016. Zika
virus. N Engl J Med. 374:15521563.
Petrovsky N, Aguilar JC. (2004) Vaccine adjuvants: current
state and future trends. Immunol cell boil. 82:488496.
Picard-Jean F, Tremblay-Ltourneau M, Serra E, Dimech C,
Schulz H, Anselin M, Dutilly V, Bisaillo M. 2013. RNA 50-end
maturation: a crucial step in the replication of viral
genomes. In: Romanowski V, editor. Current issues in Mol-
ecule Virology - Viral Genetics and Biotechnological Appli-
cations. [Internet]. [place unknown]: InTech; [cited 2016




Pierre DYS, Okechukwu EC, Nchiwan NE. 2014. Larvicidal and
phytochemical properties of Callistemon rigidus R. Br.
(Myrtaceae) leaf solvent extracts against three vector mos-
quitoes. J Vector Borne Dis. 51:216223.
Pinto VL Jr., Luz K, Parreira R, Ferrinho P. 2015. Zika virus: a
review to clinicians. Acta Med Port. 28:760765.
Pond WL. 1963. Arthropod-borne virus antibodies in sera
from residents of South-East Asia. Trans R Soc Trop Med
Hyg. 57:364371.
Pyke AT, Daly MT, Cameron JN, Moore PR, Taylor CT, Hewitson
GR, Humphreys JL, Gair R. 2014. Imported zika virus infec-
tion from the Cook Islands into Australia. PLoS Curr. 6. pii:
ecurrents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e.
Rafiei N, Hajkowicz K, Redmond A, Taylor C. 2016. First report
of Zika virus infection in a returned traveller from the Solo-
mon Islands. Med J Aust 204 :186.
Ramkumar G, Karthi, S. 2015. Adulticidal and smoke toxicity
of Cipadessa baccifera (Roth) plant extracts against
Anopheles stephensi, Aedes aegypti, and Culex quinquefas-
ciatus. Parasitol Res. 114:167173.
Rasmussen SA, Kissin DM, Yeung LF, MacFarlane K, Chu SY,
Turcios-Ruiz RM, Mitchell EW, Williams J, Fry AM, Hageman
J, et al. 2011. Pandemic influenza and pregnancy working
group. Preparing for influenza after 2009 H1N1: special
considerations for pregnant women and newborns. Am J
Obstet Gynecol. 204:S13S20.
Ratcliff RM, Chang G, Kok T, Sloots TP. 2007. Molecular diag-
nosis of medical viruses. Curr Iss Molr Biol. 9:87102.
Ray D, Shah A, Tilgner M, Guo Y, Zhao Y, Dong H, Deas TS,
Zhou Y, Li H, Shi P-Y. 2006. West Nile virus 5’-cap structure
is formed by sequential guanine N-7 and ribose 2’-O
methylations by nonstructural protein 5. J Virol.
80:83628370.
Reed SG, Orr MT, Fox CB 2013. Key roles of adjuvants in mod-
ern vaccines. Nature Med. 19:15971608.
Reis-Castro L. 2012. Genetically modified insects as a pub-
lic health tool: discussing the different bio-objectifica-
tion within genetic strategies. Croat Med J.
53:635638.
Renaudet J, Jan C, Ridet J, Adam C, Robin Y. 1978. A serologi-
cal survey of arboviruses in the human population of Sen-
egal. Bull Soc Pathol Exot Filiales. 71:131140.
Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH.
1985. Nucleotide sequence of yellow fever virus: implica-
tions for flavivirus gene expression and evolution. Science
229:726733.
Roa M. 2016. Zika virus outbreak: reproductive health and
rights in Latin America. Lancet. 387:843.
Robin Y, Mouchet J. 1975. Serological and entomological
study on yellow fever in Sierra Leone. Bull Soc Pathol Exot
Filiales. 68:249258.
VETERINARY QUARTERLY 173
Rodhain F, Gonzalez JP, Mercier E, Helynck B, Larouze B, Han-
noun C. 1989. Arbovirus infections and viral haemorrhagic
fevers in Uganda: a serological survey in Karamoja district.
Trans R Soc Trop Med Hyg. 83:851884.
Rodriguez-Morales AJ. 2015. Zika: the new arbovirus threat
for Latin America. J Infect Dev Ctries. 9:684685.
Rodriguez-Morales AJ. 2016. Zika and microcephaly in Latin
America: An emerging threat for pregnant travelers?
Travel Med Infect Dis. 14:56.
Rossi SL, Tesh RB, Azar SR, Muruato AE, Hanley KA, Auguste
AJ, Langsjoen RM, Paessler S, Vasilakis N, Weaver SC. 2016.
Characterization of a novel murine model to study Zika
virus. Am J Trop Med Hyg. doi:10.4269/ajtmh.16-0111
Roth A, Mercier A, Lepers C, Hoy D, Duituturaga S, Benyon E,
Guillaumot L, Souares Y. 2014. Concurrent outbreaks of
dengue, chikungunya and Zika virus infections  an
unprecedented epidemic wave of mosquito-borne viruses
in the Pacific 2012-2014. Euro Surveill. 19: pii: 20929.
Roze B, Najioullah F, Ferge JL, Apetse K, Brouste Y, Cesaire R,
Fagour C, Fagour L, Hochedez P, Jeannin S, et al. 2016.
Zika virus detection in urine from patients with Guillain-
Barre syndrome on Martinique. Euro Surveill. 21.
doi:10.2807/1560-7917.ES.2016.21.9.30154
Rubin EJ, Greene MF, Baden LR. 2016. Zika virus and micro-
cephaly. N Engl J Med. 374:984985.
Ryan MD, Monaghan S, Flint M. 1998. Virus-encoded protei-
nases of the Flaviviridae. J Gen Virol. 79:947959.
Sabogal-Roman JA, Murillo-Garcıa DR, Yepes-Echeverri MC,
Restrepo-Mejia JD, Granados-Alvarez S, Paniz-Mondolfi
AE, Villamil-Gomez WE, Zapata-Cerpa DC, Barreto-Rodri-
guez K, Rodrıguez-Morales AJ. 2015. Healthcare students
and workers’ knowledge about transmission, epidemiol-
ogy and symptoms of Zika fever in four cities of Colombia.
Travel Med Infect Dis. 14:5254.
Sadovsky Y, Clifton VL, Kn€ofler M. 2016. Editorial: ZIKA
virus and placenta. Placenta. 40:A1. doi:10.1016/j.
placenta.2016.03.008
Saluzzo JF, Gonzalez JP, Herve JP, Georges AJ. 1981. Serologi-
cal survey for the prevalence of certain arboviruses in the
human population of the south-east area of Central Afri-
can Republic (author’s transl). Bull Soc Pathol Exot Filiales.
74:490499.
Saluzzo JF, Ivanoff B, Languillat G, Georges AJ. 1982. Serologi-
cal survey for arbovirus antibodies in the human and sim-
ian populations of the South-East of Gabon (author’s
transl). Bull Soc Pathol Exot Filiales. 75:262266.
Salvador FS, Fujita DM. 2015. Entry routes for Zika virus in Bra-
zil after 2014 world cup: new possibilities. Travel Med
Infect Dis. 14:4951.
Sarno M, Sacramento GA, Khouri R, do Rosario MS, Costa F,
Archanjo G, Santos LA, Nery N Jr, Vasilakis N, Ko AI, de
Almeida AR. 2016. Zika virus infection and stillbirths: a
case of hydrops fetalis, hydranencephaly and fetal demise.
PLOS Negl Trop Dis. 10: e0004517.
Schuler-Faccini L, Ribeiro EM, Feitosa IM, Horovitz DD, Caval-
canti DP, Pessoa A, Doriqui MJ, Neri JI, Neto JM, Wanderley
HY, et al. 2016. Possible association between Zika virus
infection and microcephaly - Brazil, 2015. MMWR Morb
Mortal Wkly Rep. 65:5962.
Shinohara K, Kutsuna S, Takasaki T, Moi ML, Ikeda M, Kotaki A,
Yamamoto K, Fujiya Y, Mawatari M, Takeshita N, et al.
2016. Zika fever imported from Thailand to Japan, and
diagnosed by PCR in the urines. J Travel Med. 23. pii:
tav011.
Shiryaev SA, Strongin AY. 2010. Structural and functional
parameters of the flaviviral protease: a promising antiviral
drug target. Future Virol. 5:593606.
Simpson DI. 1964. Zika virus infection in man. Trans R Soc
Trop Med Hyg. 58:335338.
Singh RK, Badasara SK, Dhama K, Malik YPS. 2015. Progress
and prospects in vaccine research. In: Malik YPS, Sagar P,
Dhama K, Singh RK, editors. Current trends and future
research challenges in vaccines and adjuvants. Souvenir,
National Workshop Organized at Indian Veterinary
Research Institute, Izatnagar 243122, Bareilly, Uttar Pra-
desh, India during 1920 November 2015; pp. 119.
Sirohi D, Chen Z, Sun L, Klose T, Pierson TC, Rossmann MG,
Kuhn RJ. 2016. The 3.8 A

resolution cryo-EM structure of
Zika virus. Science. 352:467470.
SMFM Publications Committee. 2016. SMFM statement: ultra-
sound screening for fetal microcephaly following Zika
virus exposure. Am J Obstet Gynecol. doi:10.1016/j.
ajog.2016.02.043
Smit JM, Moesker B, Rodenhuis-Zybert I, Wilschut J. 2011. Flavi-
virus cell entry and membrane fusion. Viruses. 3:160171.
Smithburn KC. 1952. Neutralizing antibodies against certain
recently isolated viruses in the sera of human beings
residing in East Africa. J Immunol Baltim Md. 69:223234.
Smithburn KC. 1954. Neutralizing antibodies against arthro-
pod-borne viruses in the sera of long-time residents of
Malaya and Borneo. Am J Hyg. 59:157163.
Smithburn KC, Kerr JA, Gatne PB. 1954. Neutralizing antibod-
ies against certain viruses in the sera of residents of India.
J Immunol Baltim Md. 1950. 72:248257.
Smithburn KC, Taylor RM, Rizk F, Kader A. 1954. Immunity to
certain arthropod-borne viruses among indigenous resi-
dents of Egypt. Am J Trop Med Hyg. 3:918.
Staples JE, Dziuban EJ, Fischer M, Cragan JD, Rasmussen SA,
Cannon MJ, Frey MT, Renquist CM, Lanciotti RS, Mu~noz JL,
et al. 2016. Interim guidelines for the evaluation and test-
ing of infants with possible congenital Zika virus infection
- United States. MMWR Morb Mortal Wkly Rep. 65:6367.
Summers DJ, Acosta RW, Acosta AM. 2015. Zika virus in an
American recreational traveler. J Travel Med. 22:338340.
Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013.
MEGA6: molecular evolutionary genetics analysis version
6.0. Mol Biol Evol. 12:27252729.
Tang H, Hammock C, Ogden SC, Wen Z, Qian X, Li Y, Yao B,
Shin J, Zhang F, Lee EM, et al. 2016. Zika virus infects
human cortical neural progenitors and attenuates their
growth. Cell Stem Cell. 18:587590.
Tappe D, Nachtigall S, Kapaun A, Schnitzler P, G€unther S,
Schmidt-Chanasit J. 2015. Acute Zika virus infection after
travel to Malaysian Borneo, September 2014. Emerg Infect
Dis. 21:911913.
Tappe D, Perez-Giron JV, Zammarchi L, Rissland J, Ferreira DF,
Jaenisch T, Gomez-Medina S, G€unther S, Bartoloni A,
Mu~noz-Fontela C, Schmidt-Chanasit J. 2016. Cytokine
kinetics of Zika virus-infected patients from acute to
reconvalescent phase. Med Microbiol Immunol.
205:269273.
Tappe D, Rissland J, Gabriel M, Emmerich P, Gunther S, Held
G, Smola S, Schmidt-Chanasit J. 2014. First case of labora-
tory-confirmed Zika virus infection imported into Europe,
November 2013. Euro Surveill. 19:20685.
Tetro JA. 2016. Zika and microcephaly: causation, correlation,
or coincidence? Microbes Infect. pii: S1286-4579(16)
00008-3.
Teurlai M, Menkes CE, Cavarero V, Degallier N, Descloux E,
Grangeon JP, Guillaumot L, Libourel T, Lucio PS, Mathieu-
Daude F, Mangeas M. 2015. Socio-economic and climate
factors associated with Dengue fever spatial heterogeneity:
a worked example in New Caledonia. PLoS Negl Trop Dis.
9:e0004211.
174 R. K. SINGH ET AL.
Tiwari R, Chakraborty S, Dhama K, Wani MY, Kumar A, Kapoor
S. 2014. Wonder world of phages: potential biocontrol
agents safeguarding biosphere and health of animals and
humans - current scenario and perspectives. Pak J Biol Sci.
17:316328.
Tognarelli J, Ulloa S, Villagra E, Lagos J, Aguayo C, Fasce R,
Parra B, Mora J, Becerra N, Lagos N, et al. 2015. A report
on the outbreak of Zika virus on Easter Island, South
Pacific, 2014. Arch Virol. 161:665668.
Torjesen I. 2016. Zika virus outbreaks prompt warnings to
pregnant women. BMJ. 352:i500.
Ulmer JB, Mansoura MK, Geall AJ. 2015. Vaccines’ on
demand': science fiction or a future reality. Expert Opin
Drug Discov. 10:101116.
Van den Hurk R, Evoy S. 2015. A review of membrane-based
biosensors for pathogen detection. Sensors.
15:1404514078.
van Panhuis WG, Hyun S, Blaney K, Marques ET Jr, Coelho GE,
Siqueira JB Jr, Tibshirani R, da Silva JB Jr, Rosenfeld R.
2014. Risk of dengue for tourists and teams during the
World Cup 2014 in Brazil. PLoS Negl Trop Dis. 8:e3063.
Ventura CV, Maia M, Bravo-Filho V, Gois AL, Belfort R Jr. 2016.
Zika virus in Brazil and macular atrophy in a child with
microcephaly. Lancet 387:228.
Ventura CV, Maia M, Ventura BV, Linden VV, Araujo EB, Ramos
RC, Rocha MA, Carvalho MD, Belfort R Jr, Ventura LO.
2016. Ophthalmological findings in infants with micro-
cephaly and presumable intra-uterus Zika virus infection.
Arq Bras Oftalmol. 79:13.
Vest KG. 2016. Zika virus: a basic overview of an emerging
arboviral infection in the Western Hemisphere. Disaster
Med Public Health Prep. 29:16.
Victora CG, Schuler-Faccini L, Matijasevich A, Ribeiro E, Pessoa
A, Barros FC. 2016. Microcephaly in Brazil: how to interpret
reported numbers? Lancet. 387:621624.
Villamil-Gomez WE, Gonzalez-Camargo O, Rodriguez-Ayubi J,
Zapata-Serpa D, Rodriguez-Morales AJ. 2016. Dengue, chi-
kungunya and Zika co-infection in a patient from Colom-
bia. J Infect Public Health. pii: S1876-0341(15)00221-X.
Waggoner JJ, Pinsky BA. 2016. Zika virus: diagnostics for an
emerging pandemic threat. J Clin Microbiol. 54:860867.
Way JH, Bowen ET, Platt GS. 1976. Comparative studies of
some African arboviruses in cell culture and in mice. J Gen
Virol. 30:123130.
Weaver SC, Costa F, Garcia-Blanco MA, Ko AI, Ribeiro GS,
Saade G, Shi PY, Vasilakis N. 2016. Zika virus: history, emer-
gence, biology, and prospects for control. Antiviral Res.
130:6980.
Weinbren MP, Williams MC. 1958. Zika virus: further isolations
in the Zika area, and some studies on the strains isolated.
Trans R Soc Trop Med Hyg. 52:263268.
Wikan N, Suputtamongkol Y, Yoksan S, Smith DR, Auewar-
akul P. 2016. Immunological evidence of Zika virus
transmission in Thailand. Asian Pac J Trop Med.
9:141144.
Wolfe ND, Kilbourn AM, Karesh WB, Rahman HA, Bosi EJ,
Cropp BC, Andau M, Spielman A, Gubler DJ. 2001. Sylvatic
transmission of arboviruses among Bornean orangutans.
Am J Trop Med Hyg. 64:310316.
WHO. 2016. Disease outbreak news: Zika virus infection -
Dominican Republic. 27 January 2016 [Internet]. Geneve:
WHO; 2016.
Xiao XW, Fu HZ, Luo YH, Wei XY. 2013. Potential anti-angio-
genic sulfates of andrographolide. J Asian Nat Prod Res.
15:809818.
Zammarchi L, Stella G, Mantella A, Bartolozzi D, Tappe D,
G€unther S, Oestereich L, Cadar D, Mu~noz-Fontela C, Barto-
loni A, Schmidt-Chanasit J. 2015. Zika virus infections
imported to Italy: clinical, immunological and virological
findings, and public health implications. J Clin Virol.
63:3235.
Zammarchi L, Tappe D, Fortuna C, Remoli ME, G€unther S, Ven-
turi G, Bartoloni A, Schmidt-Chanasit J. 2015. Zika virus
infection in a traveller returning to Europe from Brazil,
March 2015. Euro Surveill. 20. pii: 21153.
Zanluca C, de Melo VC, Mosimann AL, Dos Santos GI, Dos San-
tos CN, Luz K. 2015. First report of autochthonous trans-
mission of Zika virus in Brazil. Mem Inst Oswaldo Cruz.
110:569572.
Zanluca C, dos Santos CND. 2016. Zika viruse an overview.
Microb Infect. 18:295301.
Zhang Y, Corver J, Chipman PR, Zhang W, Pletnev SV, Sedlak
D, Baker TS, Strauss JH, Kuhn RJ, Rossmann MG. 2003.
Structures of immature flavivirus particles. EMBO J.
22:26042613.
Zhou Y, Hao W, Zhao Q, Chen Y, Chen Y, Tao Y, Bai H. 2014.
Recent advances in transgenic plant-derived vaccines.
Med Plant 5:5760.
VETERINARY QUARTERLY 175
